Cataflam 50mg sugar-coated tablets
Indication
Cataflam® 50mg sugar- coated tablets can relieve symptoms of inflammation such as pain and swelling by blocking the synthesis of the molecules (prostaglandins) responsible for inflammation, pain and fever.1
Dosage
Image
| Adults: 100-150 mg per day.1 |
Image
| For milder cases and children over 14 years of age 50-100 mg per day is usually sufficient1 |
Efficacy
Cataflam® 50mg (diclofenac potassium) is more effective than 650 mg of aspirin and with a longer duration of effect (at 30 minutes, 4 and 8 hours) in severe postepisiotomy pain2
*Significantly superior to placebo.
†Significantly superior to 650 mg of aspirin.
‡Significantly superior to 25 mg of diclofenac potassium with Fisher's protected least significant differences test, p ≤ 0.05
For Cataflam® 50 mg Abbreviated prescribing information
For Cataflam® 50 mg Abbreviated prescribing information
References
Cataflam® 50 mg Egyptian Drug Authority approved insert leaflet, Approval date:,:26/12/2024.
Olson NZ, Sunshine A, ZighelboimI, et al. Onset and duration of analgesia of diclofenac potassium in the treatment of postepisiotomy pain. Am J Ther. 1997;4(7- 8):239-246..
Approved by Egyptian Drug Authority: HF0082OA4731/092025. Invalidation date: 01/09/2027.
Kindly report any violated online promotional, educational and awareness material not having this message to The General administration for Regulation of Marketing & Advertising Materials at: www.edaegypt.gov.eg
Image
|
HF0082OA4731/092025 |
Adverse Events Reporting We encourage using the following Electronic reporting tool for reporting into the safety database directly: |